FGF21 and fatty liver disease: Studies that evaluate exogenous administration of FGF21 in obese and insulin-resistant humans show significant benefits such as weight loss, reduced blood glucose, reduced cholesterols and low-density lipoproteins, and resolution of hepatic steatosis with minimal to no side effects (7–9).